Biosimilar Collaborations Ireland

Biosimilar Collaborations Ireland is a Dublin-based pharmaceutical company and a subsidiary of Amneal Pharmaceuticals. The company focuses on the development, registration, and commercialization of biosimilar products for global markets. It serves as the regulatory and intellectual property hub for Amneal's biosimilar portfolio, holding Biologics License Applications (BLAs) for several key therapies. The company's current commercial portfolio includes Alymsys, a bevacizumab biosimilar, as well as Fylnetra and Releuko, which are biosimilars for pegfilgrastim and filgrastim, respectively. Through strategic partnerships with developers like Kashiv BioSciences and Mabxience, Biosimilar Collaborations Ireland aims to expand access to high-quality, affordable biologic treatments. The entity plays a critical role in Amneal's broader strategy to become a leader in the biosimilars market.